Autolus Therapeutics (AUTL) Retained Earnings (2017 - 2026)

Autolus Therapeutics (AUTL) has 9 years of Retained Earnings data on file, last reported at $1.6 billion in Q4 2025.

• Quarterly Retained Earnings rose 0.93% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (up 0.93% YoY) and the FY2025 annual result came in at $1.6 billion, up 0.93% from the prior year.
• Retained Earnings steadied at $1.6 billion in Q4 2025, from $1.6 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.6 billion in Q4 2025 to a low of $716.5 million in Q1 2021.
• A 5-year average of $1.2 billion and a median of $1.0 billion in 2023 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings soared 52.68% — and 2025, when it rose 0.93%.
• Tracing AUTL's Retained Earnings over 5 years: stood at $843.1 million in 2021, then grew by 19.51% to $1.0 billion in 2022, then increased by 1.12% to $1.0 billion in 2023, then jumped by 52.67% to $1.6 billion in 2024, then grew by 0.93% to $1.6 billion in 2025.
• The last three Retained Earnings figures came in at $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025), per Business Quant data.